Professor Finn qualified from University College Cork in 1998, completed his higher professional training in histopathology in 2005. He subsequently worked as staff pathologist and senior scientist at the Centre for Molecular Oncologic Pathology (CMOP) at the Dana Farber Cancer Institute in Boston, USA. Professor Finn returned to Ireland in 2008 and worked as consultant pathologist at the Mid-Western Regional Hospital in Limerick before moving to his current position.

Professor Finn obtained his PhD from Trinity College Dublin (2005) and he is a fellow of the Royal College of Pathologists, UK. He is a member of the European Thoracic Oncology Platform (ETOP), he leads the Thoracic Oncology Research Group in the hospital and is associate editor of Lung Cancer Journal.

Professor Finn’s primary research interests are focused on lung and prostate cancers, including; obesity and metabolic syndrome in prostate cancer progression, the molecular significance of dietary and exercise interventions, non-coding RNA (ribonucleic acid) signatures of advanced prostate cancer, circular RNAs as biomarkers and the utility of circulating DNA and circulating tumour cells as a liquid biopsy. In addition, Professor Finn has interests relating to human cancer molecular diagnostics particularly in relation to the use of next generation sequencing for routine molecular diagnostics.